ARDS临床实践指南2021
日本重症医学会/日本呼吸学会/日本呼吸治疗学会联合委员会制定并发布ARDS临床实践指南2021。本版在成人46个临床问题基础上新增15个儿童临床问题,采用GRADE系统及推荐强度判定方法进行系统评价,并新采用诊断准确性Meta分析和网状Meta分析。成人推荐包括:限制潮气量4-8 mL/kg(GRADE 1D)、使用低剂量激素(GRADE 1B)、建议对重度ARDS实施ECMO(GRADE 2B)、不建议使用高剂量激素(GRADE 2C)等;儿童推荐包括:建议中度ARDS俯卧位(GRADE 2D)、不建议常规NO吸入(GRADE 2C)等。本文为日文完整版指南的翻译摘要。
要点
- 成人ARDS机械通气推荐限制潮气量至4-8 mL/kg(GRADE 1D)。
- 成人ARDS推荐使用低剂量激素(GRADE 1B),不建议使用高剂量激素(GRADE 2C)。
- 重度ARDS建议实施体外膜肺氧合(GRADE 2B)。
- 不建议以跨肺压作为PEEP设置的常规依据(GRADE 2B)。
- 儿童ARDS建议中度患者俯卧位(GRADE 2D),不建议常规NO吸入(GRADE 2C)。
适用人群与场景
- 成人ARDS患者(46个临床问题)
- 儿童ARDS患者(15个临床问题)
处置流程与药物剂量
- 成人ARDS机械通气:推荐限制潮气量至4-8 mL/kg(GRADE 1D)。
- 成人ARDS:不建议以血清C反应蛋白和降钙素原水平来识别细菌性肺炎作为基础疾病(GRADE 2D)。
- 成人ARDS:不建议以过度降低SpO2(PaO2)为目标的管理(GRADE 2D)。
- 成人ARDS:不建议以跨肺压作为PEEP设置的常规依据(GRADE 2B)。
- 重度ARDS:建议实施体外膜肺氧合(GRADE 2B)。
- 成人ARDS:不建议使用高剂量激素(GRADE 2C);推荐使用低剂量激素(GRADE 1B)。
- 儿童ARDS:不建议使用无创呼吸支持(无创正压通气/经鼻高流量氧疗)(GRADE 2D)。
- 儿童中度ARDS:建议俯卧位(GRADE 2D)。
研究设计与关键结果
- 指南制定机构为日本重症医学会/日本呼吸学会/日本呼吸治疗学会联合委员会,2021版在2016版成人46个临床问题基础上新增15个儿童临床问题。
- 方法学采用系统评价方法、GRADE系统及推荐强度判定方法,并新采用诊断准确性Meta分析和网状Meta分析。
证据类型、等级与局限
- 证据类型:临床实践指南(GRADE系统分级)。
- 本文为日文完整版指南的翻译摘要,原文面向日本医疗专业人员,可能包含与其他国家医疗专业人员不同的观点。
对床旁实践的改变
- 成人ARDS机械通气应限制潮气量至4-8 mL/kg(GRADE 1D)。
- 成人ARDS可使用低剂量激素(GRADE 1B),不建议使用高剂量激素(GRADE 2C)。
- 重度ARDS可考虑实施ECMO(GRADE 2B)。
- 不建议以跨肺压作为PEEP设置的常规依据(GRADE 2B)。
- 儿童中度ARDS建议俯卧位(GRADE 2D),不建议常规NO吸入(GRADE 2C),不建议每日镇静中断(GRADE 2D)。
指南或共识出处
- ARDS Clinical Practice Guideline 2021,日本重症医学会/日本呼吸学会/日本呼吸治疗学会联合委员会,2021年。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The joint committee of the Japanese Society of Intensive Care Medicine/Japanese Respiratory Society/Japanese Society of Respiratory Care Medicine on ARDS Clinical Practice Guideline has created and released the ARDS Clinical Practice Guideline 2021.
METHODS: The 2016 edition of the Clinical Practice Guideline covered clinical questions (CQs) that targeted only adults, but the present guideline includes 15 CQs for children in addition to 46 CQs for adults. As with the previous edition, we used a systematic review method with the Grading of Recommendations Assessment Development and Evaluation (GRADE) system as well as a degree of recommendation determination method. We also conducted systematic reviews that used meta-analyses of diagnostic accuracy and network meta-analyses as a new method.
RESULTS: Recommendations for adult patients with ARDS are described: we suggest against using serum C-reactive protein and procalcitonin levels to identify bacterial pneumonia as the underlying disease (GRADE 2D); we recommend limiting tidal volume to 4-8 mL/kg for mechanical ventilation (GRADE 1D); we recommend against managements targeting an excessively low SpO2 (PaO2) (GRADE 2D); we suggest against using transpulmonary pressure as a routine basis in positive end-expiratory pressure settings (GRADE 2B); we suggest implementing extracorporeal membrane oxygenation for those with severe ARDS (GRADE 2B); we suggest against using high-dose steroids (GRADE 2C); and we recommend using low-dose steroids (GRADE 1B). The recommendations for pediatric patients with ARDS are as follows: we suggest against using non-invasive respiratory support (non-invasive positive pressure ventilation/high-flow nasal cannula oxygen therapy) (GRADE 2D); we suggest placing pediatric patients with moderate ARDS in the prone position (GRADE 2D); we suggest against routinely implementing NO inhalation therapy (GRADE 2C); and we suggest against implementing daily sedation interruption for pediatric patients with respiratory failure (GRADE 2D).
CONCLUSIONS: This article is a translated summary of the full version of the ARDS Clinical Practice Guideline 2021 published in Japanese (URL: https://www.jrs.or.jp/publication/jrs_guidelines/). The original text, which was written for Japanese healthcare professionals, may include different perspectives from healthcare professionals of other countries.
参考来源
- Tasaka S, Ohshimo S, Takeuchi M, et al. ARDS clinical practice guideline 2021. Respir Investig. 2022. PMID: 35753956. doi:10.1016/j.resinv.2022.05.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。